Reimbursement of expenses incurred on COVID-19 related treatment of Smt. Madhu at Moolchand Hospital, New Delhi
GOVERNMENT OF INDIA (भारत सरकार)
MINISTRY OF RAILWAYS (रेलवे मंत्रालय)
RAILWAY BOARD (रेलवे बोर्ड)
No. 2021/H/28/Brief (Madlu)
New Delhi, dated: 18.05.2021
Principal Chief Medical Director
Baroda House, New Delhi.
Sub: Reimbursement of expenses incurred on COVID-19 related treatment of Smt. Madhu at Moolchand Hospital, New Delhi.
Ref: NR’s letter no. 99-Mcd/MR/LC/FEB-39/NR/CH/21 dated 03.04.2021.
A copy of the petition submitted by Shri Lal Chand, Retd. Rly. employee, on the above subject is enclosed herewith. While examining the issue the following observations have been made:-
“The pandemic has already been declared as a disaster and Disaster Management Act has been invoked in this regard. People are running from pillar to post to get a bed for treatment. The rates for treatment have also been notified by State Government. Hence, rejection of IPD treatment claim is not proper. With a view to contain spread of the pandemic, it has also been decided to reimburse the cost of permissible OPD medicines.
In view of above, all the zones/PUs are desired to consider such cases for reimbursement at the rate specified by the respective state governments where COVID positive reports have been submitted.
This has the approval of PED/Health as DG/RHS.
(RS Shukla) (आर.एस. शुक्ल)
Director, Health (नि./स्वा.)
Railway Board (रेलवे बोर्ड)
Copy to:- PCMDs/PCMOs All Indian Railways/PUs including RDSO/NAIR.